5 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
HF outcomes in HFrEF ... on GDMT, with or ... HF outcomes in HFrEF ... visualabstract #table ... #CVD #CKD
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Angina, HFpEF, ... HFrEF, AFib, TAA ... Dissection • CKD ... Comorbidities #pharmacology ... #table #management
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
Guideline-Directed ... ) in HFrEF and CKD ... used in HFrEF: ... #CKD #HFrEF #management ... #pharmacology #
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... ejection fraction; GDMT ... , guideline-directed ... heart failure; HFpEF ... ejection fraction; HFrEF
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Heart Failure (HFrEF ... Ejection Fraction (HFrEF ... follow Guideline-Directed ... patients with HFrEF ... #HeartFailure #HFrEF